157 related articles for article (PubMed ID: 37656908)
1. Curcumin analog GO-Y030 inhibits tumor metastasis and glycolysis.
MaruYama T; Miyazaki H; Komori T; Osana S; Shibata H; Owada Y; Kobayashi S
J Biochem; 2023 Nov; 174(6):511-518. PubMed ID: 37656908
[TBL] [Abstract][Full Text] [Related]
2. Curcumin analog GO-Y030 boosts the efficacy of anti-PD-1 cancer immunotherapy.
MaruYama T; Kobayashi S; Shibata H; Chen W; Owada Y
Cancer Sci; 2021 Dec; 112(12):4844-4852. PubMed ID: 34529884
[TBL] [Abstract][Full Text] [Related]
3. The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells.
MaruYama T; Kobayashi S; Nakatsukasa H; Moritoki Y; Taguchi D; Sunagawa Y; Morimoto T; Asao A; Jin W; Owada Y; Ishii N; Iwabuchi Y; Yoshimura A; Chen W; Shibata H
Front Immunol; 2021; 12():687669. PubMed ID: 34248973
[TBL] [Abstract][Full Text] [Related]
4. A curcumin analogue GO-Y030 depletes cancer stem cells by inhibiting the interaction between the HSP70/HSP40 complex and its substrates.
Suzuki M; Yamamoto Y; Nishijima-Matsunobu A; Kawasaki Y; Shibata H; Omori Y
FEBS Open Bio; 2023 Mar; 13(3):434-446. PubMed ID: 36648092
[TBL] [Abstract][Full Text] [Related]
5. Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030.
Lin L; Liu Y; Li H; Li PK; Fuchs J; Shibata H; Iwabuchi Y; Lin J
Br J Cancer; 2011 Jul; 105(2):212-20. PubMed ID: 21694723
[TBL] [Abstract][Full Text] [Related]
6. Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis.
Sato A; Kudo C; Yamakoshi H; Uehara Y; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
Cancer Sci; 2011 May; 102(5):1045-51. PubMed ID: 21272158
[TBL] [Abstract][Full Text] [Related]
7. Curcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomas.
Hutzen B; Friedman L; Sobo M; Lin L; Cen L; De Angelis S; Yamakoshi H; Shibata H; Iwabuchi Y; Lin J
Int J Oncol; 2009 Oct; 35(4):867-72. PubMed ID: 19724924
[TBL] [Abstract][Full Text] [Related]
8. Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo.
Shibata H; Yamakoshi H; Sato A; Ohori H; Kakudo Y; Kudo C; Takahashi Y; Watanabe M; Takano H; Ishioka C; Noda T; Iwabuchi Y
Cancer Sci; 2009 May; 100(5):956-60. PubMed ID: 19445025
[TBL] [Abstract][Full Text] [Related]
9. The Synthetic Curcumin Analogue GO-Y030 Effectively Suppresses the Development of Pressure Overload-induced Heart Failure in Mice.
Shimizu K; Sunagawa Y; Funamoto M; Wakabayashi H; Genpei M; Miyazaki Y; Katanasaka Y; Sari N; Shimizu S; Katayama A; Shibata H; Iwabuchi Y; Kakeya H; Wada H; Hasegawa K; Morimoto T
Sci Rep; 2020 Apr; 10(1):7172. PubMed ID: 32346115
[TBL] [Abstract][Full Text] [Related]
10. Synthetic Analogs of Curcumin Modulate the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCG2.
Murakami M; Ohnuma S; Fukuda M; Chufan EE; Kudoh K; Kanehara K; Sugisawa N; Ishida M; Naitoh T; Shibata H; Iwabuchi Y; Ambudkar SV; Unno M
Drug Metab Dispos; 2017 Nov; 45(11):1166-1177. PubMed ID: 28904007
[TBL] [Abstract][Full Text] [Related]
11. Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma.
Kudo C; Yamakoshi H; Sato A; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
Anticancer Res; 2011 Nov; 31(11):3719-26. PubMed ID: 22110192
[TBL] [Abstract][Full Text] [Related]
12. Correction to: Curcumin analog GO-Y030 inhibits tumor metastasis and glycolysis.
J Biochem; 2024 Feb; 175(2):215. PubMed ID: 37982668
[No Abstract] [Full Text] [Related]
13. TGF-β-mediated exosomal lnc-MMP2-2 regulates migration and invasion of lung cancer cells to the vasculature by promoting MMP2 expression.
Wu DM; Deng SH; Liu T; Han R; Zhang T; Xu Y
Cancer Med; 2018 Oct; 7(10):5118-5129. PubMed ID: 30256540
[TBL] [Abstract][Full Text] [Related]
14. Structure-Activity Relationships of the Antitumor C5-Curcuminoid GO-Y030.
Kohyama A; Yamakoshi H; Hongo S; Kanoh N; Shibata H; Iwabuchi Y
Molecules; 2015 Aug; 20(8):15374-91. PubMed ID: 26305242
[TBL] [Abstract][Full Text] [Related]
15. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF).
Lin SS; Lai KC; Hsu SC; Yang JS; Kuo CL; Lin JP; Ma YS; Wu CC; Chung JG
Cancer Lett; 2009 Nov; 285(2):127-33. PubMed ID: 19477063
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of Water-Soluble Prodrugs of C5-Curcuminoid GO-Y030 Based on Reversible Thia-Michael Reaction.
Yamakoshi H; Fukuda M; Ikeda H; Fujiki S; Kohyama A; Nagasawa S; Shinozaki H; Shibata H; Iwabuchi Y
Chem Pharm Bull (Tokyo); 2024; 72(1):127-134. PubMed ID: 38296515
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo.
Kudo C; Yamakoshi H; Sato A; Nanjo H; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
BMC Pharmacol; 2011 May; 11():4. PubMed ID: 21619659
[TBL] [Abstract][Full Text] [Related]
18. Cyclohexanone curcumin analogs inhibit the progression of castration-resistant prostate cancer in vitro and in vivo.
Mapoung S; Suzuki S; Fuji S; Naiki-Ito A; Kato H; Yodkeeree S; Ovatlarnporn C; Takahashi S; Limtrakul Dejkriengkraikul P
Cancer Sci; 2019 Feb; 110(2):596-607. PubMed ID: 30499149
[TBL] [Abstract][Full Text] [Related]
19. Curcumin Inhibits LIN-28A through the Activation of miRNA-98 in the Lung Cancer Cell Line A549.
Liu WL; Chang JM; Chong IW; Hung YL; Chen YH; Huang WT; Kuo HF; Hsieh CC; Liu PL
Molecules; 2017 Jun; 22(6):. PubMed ID: 28587210
[TBL] [Abstract][Full Text] [Related]
20. A Curcumin Analog, GO-Y078, Effectively Inhibits Angiogenesis through Actin Disorganization.
Sugiyama S; Yoshino Y; Kuriyama S; Inoue M; Komine K; Otsuka K; Kohyama A; Yamakoshi H; Ishioka C; Tanaka M; Iwabuchi Y; Shibata H
Anticancer Agents Med Chem; 2016; 16(5):633-47. PubMed ID: 26459768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
